Vaccine hesitancy: the next challenge in the fight against COVID-19.
Amiel A. Dror,Netanel Eisenbach,Shahar Taiber,Nicole G. Morozov,Matti Mizrachi,Asaf Zigron,Samer Srouji,Eyal Sela +7 more
TLDR
It is indicated that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to CO VID-19 vaccination if and when available, and parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy.Abstract:
Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires completed by healthcare workers and members of the general Israeli population, regarding acceptance of a potential COVID-19 vaccine. Our results indicate that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to COVID-19 vaccination if and when available. In contrast, parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy. Interventional educational campaigns targeted towards populations at risk of vaccine hesitancy are therefore urgently needed to combat misinformation and avoid low inoculation rates.read more
Citations
More filters
Journal ArticleDOI
Nationwide Deployment of a Serious Game Designed to Improve COVID-19 Infection Prevention Practices in Switzerland: Prospective Web-Based Study.
Mélanie Suppan,Loric Stuby,Stéphan Juergen Harbarth,Christophe Fehlmann,Sophia Achab,Sophia Achab,Mohamed Abbas,Laurent Suppan +7 more
TL;DR: The ESCAPE COVID-19 game as discussed by the authors is a serious game for teaching COVID19 infection prevention and control practices that has previously been validated in a population of nursing home personnel and participants were asked to complete a short demographic questionnaire before accessing the serious game.
Posted ContentDOI
Covid-19 vaccination intentions among Canadian parents of 9-12 year old children: results from the All Our Families longitudinal cohort
Erin Hetherington,Erin Hetherington,Sarah A Edwards,Shannon E. MacDonald,Shannon E. MacDonald,Nicole Racine,Nicole Racine,Sheri Madigan,Sheri Madigan,Sheila McDonald,Suzanne Tough,Suzanne Tough +11 more
TL;DR: Almost a third of parents remain unsure about vaccinating their children against COVID-19, even within a group with historically high uptake of infant vaccines.
Journal ArticleDOI
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
Miguel García-Grimshaw,Santa Elizabeth Ceballos-Liceaga,Anaclara Michel-Chávez,Mario García-Alanis,Arturo Cadena-Fernández,Javier A. Galnares-Olalde,Guillermo Carbajal-Sandoval,Daniel Amado Carrillo-García,Noé Hernández-Valdivia,Laura E. Hernández-Vanegas,María del Mar Saniger-Alba,Alonso Gutierrez-Romero,José Luis Díaz-Ortega,Gustavo Reyes-Terán,Hugo López-Gatell,Fernando Flores-Silva,Carlos Cantú-Brito,Erwin Chiquete,Antonio Arauz,Sergio I. Valdés-Ferrer +19 more
TL;DR: In this paper, the authors evaluated NSSS from a cohort of 7,812,845 BNT162b2 first-dose recipients, of whom 10,929 reported an adverse event following immunization (AEFI).
Journal ArticleDOI
Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants
TL;DR: In this paper , the authors conducted an online survey in five countries (Egypt, Iraq, Palestine, Saudi Arabia, and Sudan) in November and December 2021 to determine COVID-19 vaccine booster acceptance and its associated factors in the general population in the MENA region to attain public herd immunity.
Journal ArticleDOI
Counties with Lower Insurance Coverage and Housing Problems Are Associated with Both Slower Vaccine Rollout and Higher COVID-19 Incidence.
TL;DR: In this article, the impact of demographic, socioeconomic, and environmental factors on county-level vaccination rates and COVID-19 incidence changes is assessed using multivariate linear regression to adjust for age as a potential confounding variable.
References
More filters
Journal ArticleDOI
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science.
Emily A. Holmes,Emily A. Holmes,Rory C. O'Connor,V. Hugh Perry,Irene Tracey,Simon Wessely,Louise Arseneault,Clive Ballard,Helen Christensen,Roxane Cohen Silver,Ian P. Everall,Tamsin Ford,Ann John,Thomas Kabir,Kate King,Ira Madan,Susan Michie,Andrew K. Przybylski,Roz Shafran,Angela Sweeney,Carol M. Worthman,Lucy Yardley,Katherine Cowan,Claire Cope,Matthew Hotopf,Edward T. Bullmore +25 more
TL;DR: There is an urgent need for research to address how mental health consequences for vulnerable groups can be mitigated under pandemic conditions, and on the impact of repeated media consumption and health messaging around COVID-19.
Journal ArticleDOI
Covid-19: risk factors for severe disease and death.
TL;DR: A long list is emerging from largely unadjusted analyses, with age near the top of the list of top 10 causes of death in the world of sport.
Journal ArticleDOI
Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases
TL;DR: Although some clinicians have discontinued or have considered discontinuing their provider relationship with patients who refuse vaccines, the American Academy of Pediatrics Committee on Bioethics recommends that clinicians address vaccine refusal by respectfully listening to parental concerns and discussing the risks of nonvaccination.
Journal ArticleDOI
A strategic approach to COVID-19 vaccine R&D.
TL;DR: The ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines) public-private partnership brings together the strengths of all sectors at this time of global urgency and a collaborative platform for conducting harmonized, randomized controlled vaccine efficacy trials is discussed.